Ticker Launch
Sign inTry it free

SPAC · Merger completed

Bull Horn Holdings Corp.

Business combination with Coeptis Therapeutics, Inc.

Bull Horn Holdings Corp. is a blank-check company (SPAC) that raised $75M in its initial public offering on Nov 2, 2020. It completed its business combination with Coeptis Therapeutics, Inc. on Oct 28, 2022; the combined company is Coeptis Therapeutics Holdings, Inc. (COEP). Ellenoff Grossman & Schole advised the SPAC and White & Case advised the underwriters on the IPO.

Coeptis Therapeutics is a biopharmaceutical company developing cell therapy platforms for cancer. Its portfolio includes CD38-GEAR-NK, a cell therapy, and CD38-Diagnostic, an in vitro diagnostic, both targeting CD38-related cancers and developed with VyGen-Bio and Karolinska Institutet researchers.

Status
Merger completed
IPO date
Nov 2, 2020
IPO size
$75M
Target
Coeptis Therapeutics, Inc.
Announced
Apr 19, 2022
Closed
Oct 28, 2022
Combined company
Coeptis Therapeutics Holdings, Inc. (COEP)
SPAC counsel (IPO)
Ellenoff Grossman & Schole and Ogier
Underwriters' counsel (IPO)
White & Case

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022